Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia

被引：0
|
作者：
Metaxa, V. [1 ]
Skoumas, I. [1 ]
Pitsavos, C. [1 ]
Oikonomou, E. [1 ]
Tsetsekou, E. [1 ]
Chrysochoou, C. [1 ]
Masoura, C. [1 ]
Stefanadis, C. [1 ]
机构：
[1] Univ Athens, Hippokrat Hosp, Dept Cardiol 1, Athens, Greece
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：548 / 548
页数：1
相关论文
共 50 条
  • [1] EVALUATION OF CHOLESTEROL LOWERING TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Metaxa, V.
    Skoumas, I.
    Pitsavos, C.
    Oikonomou, E.
    Tsetsekou, E.
    Chrysochoou, C.
    Masoura, K.
    Stefanadis, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 152 - 152
  • [2] Evaluation of additional cholesterol lowering effect of ezetimibe in the treatment of familial hypercholesterolemia
    Fredenrich, A.
    Benlian, P.
    Bayer, P.
    Canivet, B.
    DIABETES & METABOLISM, 2012, 38 : A73 - A73
  • [3] Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: A large cross-sectional study in The Netherlands
    Pijlman, A. H.
    Huijgen, R.
    Verhagen, S. N.
    Imholz, B. P. M.
    Liem, A. H.
    Kastelein, J. J. P.
    Abbink, E. J.
    Stalenhoef, A. F. H.
    Visseren, F. L. J.
    ATHEROSCLEROSIS, 2010, 209 (01) : 189 - 194
  • [4] LDL-CHOLESTEROL LOWERING TREATMENT CHANGES HEMATOPOIETIC STEM CELL BEHAVIOR IN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS
    Stiekema, L.
    Zeerleder, S. S.
    Homburg, C. H.
    Voermans, C.
    Stroes, E. S. G.
    Kroon, J.
    ATHEROSCLEROSIS, 2019, 287 : E12 - E12
  • [5] NORMALIZATION OF LYMPHOCYTE LDL RECEPTOR FUNCTION IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS AFTER TREATMENT WITH CHOLESTEROL LOWERING DRUGS
    CUTHBERT, JA
    LIPSKY, PE
    CLINICAL RESEARCH, 1988, 36 (03): : A603 - A603
  • [6] Myeloperoxidase expression is reduced upon cholesterol lowering in familial hypercholesterolemia
    Puntoni, M.
    Bigazzi, F.
    Minichilli, F.
    Sbrana, R.
    Bionda, A.
    Sampietro, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 144 - 144
  • [7] Myeloperoxidase expression is reduced upon cholesterol lowering in familial hypercholesterolemia
    Puntoni, M.
    Bigazzi, F.
    Minichilli, F.
    Sbrana, F.
    Bionda, A.
    Sampietro, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 225 - 225
  • [8] Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia
    Li, Zhi-Zhao
    Huang, Qiong
    Yang, Xiao-Li
    Zeng, Jieqiong
    Wang, Qi-Hui
    Tang, Hai-Ming
    Yu, Zhen-Qiu
    Song, Yu-Qing
    Liu, Yang
    DISEASE MARKERS, 2022, 2022
  • [9] FURTHER CHOLESTEROL LOWERING INDUCED BY PROBUCOL IN FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH CHOLESTYRAMINE
    SCHOUTEN, JA
    DANNER, SA
    HOEK, FJ
    SPAAIJ, CJK
    BEYNEN, AC
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 48 (06): : 985 - 990
  • [10] The effect of lipid-lowering treatment on indices of MASLD in familial hypercholesterolemia patients
    Boutari, Chrysoula
    Rizos, Christos, V
    Liamis, George
    Skoumas, Ioannis
    Rallidis, Loukianos
    Garoufi, Anastasia
    Kolovou, Genovefa
    Sfikas, George
    Tziomalos, Konstantinos
    Skalidis, Emmanouil
    Kotsis, Vasileios
    Doumas, Michalis
    Stamatelopoulos, Kimon
    Lambadiari, Vaia
    Anagnostis, Panagiotis
    Boufidou, Amalia
    Giannakopoulou, Vasiliki
    Anastasiou, Georgia
    Petkou, Ermioni
    Vlachopoulos, Charalambos
    Dima, Ioanna
    Fakas, Georgios
    Papathanasiou, Konstantinos A.
    Attilakos, Achilleas
    Kolovou, Vana
    Koumaras, Charalambos
    Agapakis, Dimitrios
    Zacharis, Evangelos
    Antza, Christina
    Milionis, Haralampos
    Liberopoulos, Evangelos
    Mantzoros, Christos S.
    CLINICAL NUTRITION, 2024, 43 (12) : 84 - 91
12345